Company
Headquarters: New Taipei City, Taiwan
CEO: Gene Chen
TW$2.11 Billion
TWD as of Jan. 1, 2024
US$68.8 Million
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $207.62 B |
| Danaher | $171.89 B |
| Siemens Healthineers AG | $66.05 B |
| DexCom, Inc. | $46.50 B |
| IDEXX Laboratories, Inc. | $44.72 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
DIVA Laboratories, Ltd. manufactures and sells display solutions worldwide. It provides endo/surgical displays, which provide static and dynamic images for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging; touch displays; and displays to ODM and OEM customers. The company is headquartered in New Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
DIVA Laboratories Ltd has the following listings and related stock indices.
Stock: TWSE: 4153 wb_incandescent